Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12065405 Prodrugs and conjugates of dimethyltryptamine

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 Aug, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 21 Aug, 2024
Edits made to:
Infobox (+24 properties)
‌

 US Patent 12065405 Prodrugs and conjugates of dimethyltryptamine

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120654050
Patent Inventor Names
Glenn Short0
Robert B. Perni0
Srinivas G. Rao0
Tanweer A. Khan0
Date of Patent
August 20, 2024
0
Patent Application Number
182993470
Date Filed
April 12, 2023
0
Patent Citations
‌
US Patent 8268856 Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter
0
‌
US Patent 9388395 Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
0
‌
US Patent 9720005 Immunoassay for compounds of the NBOMe family
0
‌
US Patent 11242318 Deuterated tryptamine derivatives and methods of use
0
‌
US Patent 11332441 Crystalline N-methyl tryptamine derivatives
0
‌
US Patent 11602521 N,N-dimethyltryptamine compositions and methods
0
‌
US Patent 11643391 Prodrugs and conjugates of dimethyltryptamine
0
Patent Primary Examiner
‌
Rebecca L Anderson
0
CPC Code
‌
C07D 209/14
0
‌
C07D 209/16
0
‌
C07D 209/12
0
‌
C07D 209/08
0
‌
C07D 403/06
0
‌
C07D 401/06
0

Find more entities like US Patent 12065405 Prodrugs and conjugates of dimethyltryptamine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo